HPV DNA testing

HPV DNA testing has been studied in 8 papers since 2025: 4 observational studies in people, 1 review; 8 in the past year. The newest paper, Nov 19, 2026: “Comparative cost-effectiveness of HPV mRNA and DNA testing for anal cancer screening in MSM living with HIV: a model-based study”.

Exposure

8 papers study it1 findingUpdated

3 new papers in 30 daysSee all 8 papers on HPV DNA testing

Cells, worms or flies, mice and humans: nothing yet.
  • Funders: Gouvernement du Canada | Canadian Institutes of Health Research and 1 more
  • Humans4
  • In silico3

What did studies of HPV DNA testing find?

1

Studies of HPV DNA testing measured one outcome, Expected net monetary benefit.

Expected net monetary benefit

upin silico1

1 study
  1. HPV DNA testing increases expected net monetary benefit in silico (Peru; under modeled assumptions).

    “Clinician-collected HPV testing at 90% maximized expected net monetary benefit under modeled assumptions”

    In silicoPeru; under modeled assumptionsclinician-collected90% coveragelifetimefemales

    Scaling up primary HPV DNA screening and self-sampling for cervical cancer in Peru: Coverage, cost-utility, and budget impact analysis using public data sources

    Journal of medical screening

Funding

2 grants since 2016

National Health and Medical Research CouncilA$891KGouvernement du Canada | Canadian Institutes of Health Research

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 2Nov 2026: 27 papers in 12 months